MSOS Discussion Board

Smart pump library for home TPN patients

Rebecca Ellis's picture

Forums: 

We recently implemented IV smart pumps with a provincial drug library. We have several patients on home TPN, for whom we've also ordered new pumps. I'm just wondering for any sites who use IV smart pumps with drug libraries, do you also provide a drug library for your home TPN patients, or do you have them continue to manually program their pumps volumetrically (mL/h)? We're thinking of creating a separate smaller library specific to the home TPN patients.

ADC time outs

Dominic Saladino's picture

Forums: 

Hello,
Does anyone have any guidelines or standards that discusses time outs for the ADC s? For example, currently if the drawer is open for more than 1 min 30 sec an alert shows up to close the drawer and signs the person out of the ADC. My question is what times frames have been deemed appropriate? Our pharm techs are asking to have that time frame extended because they are doing legitimate outdates in the drawer, however I am concerned nurses could leave it the drawer open accidentally and someone unauthorized could get access. Thank you.

Scopolamine patch - new packaging

Marina Rabin's picture

Forums: 

Good Morning,
We are having quite a discussion about how to build scopolamine patch whose outer wrapping information was recently changed by manufacturers to depict, more accurately, how much drug gets delivered in 72 hours (or how they put it in 3 days).
Any institutions made the change in their CPOE yet? Curious how you handled it.
Did you leave the build as is and put a note in admin instructions " each patch delivers 1 mG/72 hours"
Or, you completely rebuilt CPOE generic item to reflect packaging change?
Thanks,
Marina.

Timing of medications

Randi Trope's picture

Forums: 

When a new order is written for an existing medication (i.e. changing the dose or changing the frequency) who is responsible for making sure the timing of the new order goes to the MAR at the correct time based on the last dose given? Is this the responsibility of the prescriber? the verifying pharmacist? or the RN utilizing the retiming option?

Thanks,

Randi

Patient's Own Medication (medication brought by the patient at the time of admission)

SYED ZIA UL ARIFEEN's picture

Forums: 

Greetings for all,
Our hospital is accredited by the national board and the Joint Commission International.
We had an incidence wherein a patient refused to handover the medications brought by him at the time of admission (Patient's Own Medications). Some of these medications were to be continued during the hospital stay as per the order of the treating physician. (As per our policy these medications should be taken over by the pharmacy and dispensed as unit dose on daily basis.

Dual Sign guidelines

Lindsey M Eick's picture

Forums: 

We have had several requests (often in response to safety incidences) to make medications be dual sign in the EHR (Epic is our platform). In evaluating these requests it has come to light that we have no guiding principles to determine if a medication should be dual sign or not. Currently all chemo, investigational, epidural/PCA's and some medications on our high alert policy require a dual sign at the time of documentation on the MAR.

Concentrated morphine - high alert list? LASA list? Neither?

Jennifer Panic's picture

Forums: 

In updating our LASA system-wide policy, we have considered adding morphine oral liquid concentrate and morphine non-concentrated liquid. This pair is on ISMP's list of confused drug names. However, opioids are on our high alert medication policy. We were wondering if that's enough? Does your organization include this pair in your LASA policy? What strategies do you use to prevent a mix-up between these drugs in the ambulatory and acute care setting?

Reversal Agents for Angioedema LIsted on Stroke Thrombolytic Therapy Order Set

Julie Seidlinger's picture

Forums: 

Warm greetings!

Does your facility's order set for Stroke alteplase orders also include reversal agents for angioedema?

During my facility's stroke survey, the surveyor recommended adding reversal agents for angioedema as part of the standard Stroke Thrombolytics Therapy order set. She stated there is an increasing incidence of angioedema (1 to 5% incidence) with alteplase, most notably in patients also on ACE Inhibitors.

Pages

Subscribe to RSS - MSOS Discussion Board